In This Article:
As global markets face pressures from rising U.S. Treasury yields, the Hong Kong market has experienced a decline in its benchmark Hang Seng Index, reflecting broader economic uncertainties and investor caution. In this environment, dividend stocks can offer a measure of stability and income potential for investors looking to navigate these turbulent times.
Top 10 Dividend Stocks In Hong Kong
Name | Dividend Yield | Dividend Rating |
China Hongqiao Group (SEHK:1378) | 9.40% | ★★★★★☆ |
Bank of China (SEHK:3988) | 7.12% | ★★★★★☆ |
Playmates Toys (SEHK:869) | 8.70% | ★★★★★☆ |
China Construction Bank (SEHK:939) | 7.20% | ★★★★★☆ |
PC Partner Group (SEHK:1263) | 8.73% | ★★★★★☆ |
Chongqing Rural Commercial Bank (SEHK:3618) | 7.30% | ★★★★★☆ |
Tianjin Development Holdings (SEHK:882) | 7.13% | ★★★★★☆ |
China Mobile (SEHK:941) | 6.69% | ★★★★★☆ |
Shougang Fushan Resources Group (SEHK:639) | 10.00% | ★★★★★☆ |
Sinopharm Group (SEHK:1099) | 4.82% | ★★★★★☆ |
Click here to see the full list of 91 stocks from our Top SEHK Dividend Stocks screener.
Let's uncover some gems from our specialized screener.
JBM (Healthcare)
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: JBM (Healthcare) Limited is an investment holding company involved in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products across Hong Kong, Macau, Mainland China, and internationally with a market cap of HK$802.72 million.
Operations: JBM (Healthcare) Limited generates its revenue through three main segments: Branded Medicines (HK$190.11 million), Health and Wellness Products (HK$72.19 million), and Proprietary Chinese Medicines (HK$386.12 million).
Dividend Yield: 8.3%
JBM (Healthcare) recently announced a final dividend of HK$0.0405 per share, supported by a payout ratio of 50.8% and cash payout ratio of 36.7%, indicating dividends are well-covered by earnings and cash flows. Despite only two years of dividend payments, the company shows reliability with stable growth in dividends and earnings increasing by 128.5% last year. A recent buyback program could enhance net asset value per share, potentially benefiting future dividends.
-
Click here to discover the nuances of JBM (Healthcare) with our detailed analytical dividend report.
Pak Fah Yeow International
Simply Wall St Dividend Rating: ★★★★★☆
Overview: Pak Fah Yeow International Limited is an investment holding company that manufactures, markets, and distributes healthcare products under the Hoe Hin brand name, with a market cap of HK$782.22 million.
Operations: Pak Fah Yeow International Limited generates revenue from its healthcare segment amounting to HK$247.67 million, property investments at HK$10.03 million, and treasury investments totaling HK$7.52 million.